Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ian Walters"'
Autor:
Andrew Haydon, Louise M. Nott, Timothy J. Price, John Simes, Michael B. Sawyer, Danielle Charpentier, Malcolm J. Moore, Derek J. Jonker, Jeremy Shapiro, Nadine M Magoski, Jehan Siddiqui, Christos S. Karapetis, Michael Jefford, Lillian L. Siu, John Zalcberg, Ian Walters, Christopher J. O'Callaghan, Winston Liauw, Félix Couture, Dongsheng Tu
Publikováno v:
Journal of Clinical Oncology. 30:3504-3504
3504 Background: The anti-EGFR monoclonal antibody CET has improved survival in pts with chemotherapy refractory, K-RAS WT mCRC. BRIV is a potent inhibitor of multiple receptor tyrosine kinases including both VEGFR and FGFR. The combination of CET an
Autor:
Andrew Strickland, Christopher J. O'Callaghan, Fabyolla El-Tahche, Jennifer Shannon, Derek J. Jonker, Heather-Jane Au, Lillian L. Siu, Jeremy Shapiro, Muhammad Salim, Ian Walters, Malcolm J. Moore, Rami Kotb, John Zalcberg, Mark Jeffery, Dongsheng Tu, Jacob C. Easaw, Jolie Ringash, Sabe Sabesan, Siobhan Ng, Thierry Alcindor
Publikováno v:
Journal of Clinical Oncology. 30:542-542
542 Background: The CO.20 trial randomized pts with K-RAS WT chemotherapy refractory mCRC to receive CET + BRIV (Arm A) or CET + placebo (Arm B). Although overall survival (primary endpoint) was not significantly improved (HR=0.88, p=0.12) in this he